Advertisement
Screener

EXICURE, INC. (XCUR) Increase (Decrease) in Accounts Payable

2.8 / 5 stars · 68/120 Roast Me

EXICURE, INC. Increase (Decrease) in Accounts Payable

EXICURE, INC. (XCUR) reported Increase (Decrease) in Accounts Payable of $495.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.

Financial Statements › Cash Flow › Operating Activities

us-gaap:IncreaseDecreaseInAccountsPayable · last filed 2026-08-14

  • EXICURE, INC. increase (decrease) in accounts payable for the quarter ending 2026-06-30 was -$260.00K, a 135.62% decline year-over-year.
  • EXICURE, INC. increase (decrease) in accounts payable for the quarter ending 2026-03-31 was $755.00K.
  • EXICURE, INC. increase (decrease) in accounts payable for the quarter ending 2025-12-31 was $404.00K, a 304.00% increase year-over-year.
  • EXICURE, INC. increase (decrease) in accounts payable for the quarter ending 2025-09-30 was -$530.00K.
  • EXICURE, INC. increase (decrease) in accounts payable for fiscal 2025 was $177.00K.
  • EXICURE, INC. increase (decrease) in accounts payable for fiscal 2024 was -$193.00K, a 115.20% decline from fiscal 2023.
  • EXICURE, INC. increase (decrease) in accounts payable for fiscal 2023 was $1.27M.
  • EXICURE, INC. increase (decrease) in accounts payable for fiscal 2022 was -$3.05M, a 292.92% decline from fiscal 2021.
Period endIncrease (Decrease) in Accounts Payable 3 monthIncrease (Decrease) in Accounts Payable 6 monthIncrease (Decrease) in Accounts Payable 9 monthIncrease (Decrease) in Accounts Payable 12 month
2026-06-30-$260.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14
$495.00K
10-Q · filed 2026-08-14
$899.00K
derived: sum of 3 quarters · filed 2026-08-14
$369.00K
derived: sum of 4 quarters · filed 2026-08-14
2026-03-31$755.00K
10-Q · filed 2026-05-29
$1.16M
derived: sum of 2 quarters · filed 2026-05-29
$629.00K
derived: sum of 3 quarters · filed 2026-05-29
$1.36M
derived: sum of 4 quarters · filed 2026-08-14
2025-12-31$404.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25
-$126.00K
derived: sum of 2 quarters · filed 2026-03-25
$604.00K
derived: sum of 3 quarters · filed 2026-08-14
$177.00K
10-K · filed 2026-03-25
2025-09-30-$530.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07
$200.00K
derived: sum of 2 quarters · filed 2026-08-14
-$227.00K
10-Q · filed 2025-11-07
-$127.00K
derived: sum of 4 quarters · filed 2026-08-14
2025-06-30$730.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14
$303.00K
10-Q · filed 2026-08-14
$403.00K
derived: sum of 3 quarters · filed 2026-08-14
$156.00K
derived: sum of 4 quarters · filed 2026-08-14
2025-03-31-$427.00K
10-Q · filed 2026-05-29
-$327.00K
derived: sum of 2 quarters · filed 2026-05-29
-$574.00K
derived: sum of 3 quarters · filed 2026-05-29
-$814.00K
derived: sum of 4 quarters · filed 2026-05-29
2024-12-31$100.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25
-$147.00K
derived: sum of 2 quarters · filed 2026-03-25
-$387.00K
derived: sum of 3 quarters · filed 2026-03-25
-$193.00K
10-K · filed 2026-03-25
2024-09-30-$247.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07
-$487.00K
derived: sum of 2 quarters · filed 2025-11-07
-$293.00K
10-Q · filed 2025-11-07
$473.00K
derived: sum of 4 quarters · filed 2025-11-07
2024-06-30-$240.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-08
-$46.00K
10-Q · filed 2025-08-08
$720.00K
derived: sum of 3 quarters · filed 2025-08-08
$1.24M
derived: sum of 4 quarters · filed 2025-08-08
2024-03-31$194.00K
10-Q · filed 2025-06-27
$960.00K
derived: sum of 2 quarters · filed 2025-06-27
$1.48M
derived: sum of 3 quarters · filed 2025-06-27
$1.37M
derived: sum of 4 quarters · filed 2025-06-27
2023-12-31$766.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-18
$1.29M
derived: sum of 2 quarters · filed 2025-03-18
$1.18M
derived: sum of 3 quarters · filed 2025-03-18
$1.27M
10-K · filed 2025-03-18
2023-09-30$522.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14
$413.00K
derived: sum of 2 quarters · filed 2024-11-14
$504.00K
10-Q · filed 2024-11-14
-$55.00K
derived: sum of 4 quarters · filed 2024-11-14
2023-06-30-$109.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-13
-$18.00K
10-Q · filed 2024-08-13
-$577.00K
derived: sum of 3 quarters · filed 2024-08-13
-$1.25M
derived: sum of 4 quarters · filed 2024-08-13
2023-03-31$91.00K
10-Q · filed 2024-06-17
-$468.00K
derived: sum of 2 quarters · filed 2024-06-17
-$1.14M
derived: sum of 3 quarters · filed 2024-06-17
-$1.47M
derived: sum of 4 quarters · filed 2024-06-17
2022-12-31-$559.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2024-06-06
-$1.23M
derived: sum of 2 quarters · filed 2024-06-06
-$1.56M
derived: sum of 3 quarters · filed 2024-06-06
-$3.05M
10-K · filed 2024-06-06
2022-09-30-$673.00K
derived: 10-Q 9 month − 10-Q/A 6 month · filed 2024-05-16
-$998.00K
derived: sum of 2 quarters · filed 2024-06-06
-$2.49M
10-Q · filed 2024-05-16
-$1.54M
derived: sum of 4 quarters · filed 2024-06-06
2022-06-30-$325.00K
derived: 10-Q/A 6 month − 10-Q/A 3 month · filed 2024-06-06
-$1.82M
10-Q/A · filed 2024-06-06
-$867.00K
derived: sum of 3 quarters · filed 2024-06-06
-$653.00K
derived: sum of 4 quarters · filed 2024-06-06
2022-03-31-$1.50M
10-Q/A · filed 2024-06-06
-$542.00K
derived: sum of 2 quarters · filed 2024-06-06
-$328.00K
derived: sum of 3 quarters · filed 2024-06-06
-$1.02M
derived: sum of 4 quarters · filed 2024-06-06
2021-12-31$953.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-27
$1.17M
derived: sum of 2 quarters · filed 2023-03-27
$479.00K
derived: sum of 3 quarters · filed 2023-03-27
$1.58M
10-K · filed 2023-03-27
2021-09-30$214.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14
-$474.00K
derived: sum of 2 quarters · filed 2022-11-14
$629.00K
10-Q · filed 2022-11-14
$458.00K
derived: sum of 4 quarters · filed 2022-11-14
2021-06-30-$688.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-15
$415.00K
10-Q · filed 2022-08-15
$244.00K
derived: sum of 3 quarters · filed 2022-08-15
$757.00K
derived: sum of 4 quarters · filed 2022-08-15
2021-03-31$1.10M
10-Q · filed 2022-05-16
$932.00K
derived: sum of 2 quarters · filed 2022-05-16
$1.45M
derived: sum of 3 quarters · filed 2022-05-16
-$340.00K
derived: sum of 4 quarters · filed 2022-05-16
2020-12-31-$171.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-25
$342.00K
derived: sum of 2 quarters · filed 2022-03-25
-$1.44M
derived: sum of 3 quarters · filed 2022-03-25
$364.00K
10-K · filed 2022-03-25
2020-09-30$513.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-19
-$1.27M
derived: sum of 2 quarters · filed 2021-11-19
$535.00K
10-Q · filed 2021-11-19
$706.00K
derived: sum of 4 quarters · filed 2021-11-19
2020-06-30-$1.78M
derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-12
$22.00K
10-Q · filed 2021-08-12
$193.00K
derived: sum of 3 quarters · filed 2021-08-12
$408.00K
derived: sum of 4 quarters · filed 2021-08-12
2020-03-31$1.81M
10-Q · filed 2021-05-12
$1.98M
derived: sum of 2 quarters · filed 2021-05-12
$2.19M
derived: sum of 3 quarters · filed 2021-05-12
$2.24M
derived: sum of 4 quarters · filed 2021-05-12
2019-12-31$171.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-11
$386.00K
derived: sum of 2 quarters · filed 2021-03-11
$435.00K
derived: sum of 3 quarters · filed 2021-03-11
$789.00K
10-K · filed 2021-03-11
2019-09-30$215.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-12
$264.00K
derived: sum of 2 quarters · filed 2020-11-12
$618.00K
10-Q · filed 2020-11-12
-$217.00K
derived: sum of 4 quarters · filed 2020-11-12
2019-06-30$49.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-12
$403.00K
10-Q · filed 2020-08-12
-$432.00K
derived: sum of 3 quarters · filed 2020-08-12
-$151.00K
derived: sum of 4 quarters · filed 2020-08-12
2019-03-31$354.00K
10-Q · filed 2020-05-14
-$481.00K
derived: sum of 2 quarters · filed 2020-05-14
-$200.00K
derived: sum of 3 quarters · filed 2020-05-14
-$83.00K
derived: sum of 4 quarters · filed 2020-05-14
2018-12-31-$835.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-10
-$554.00K
derived: sum of 2 quarters · filed 2020-03-10
-$437.00K
derived: sum of 3 quarters · filed 2020-03-10
-$557.00K
10-K · filed 2020-03-10
2018-09-30$281.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-07
$398.00K
derived: sum of 2 quarters · filed 2019-11-07
$278.00K
10-Q · filed 2019-11-07
-$888.00K
derived: sum of 4 quarters · filed 2019-11-07
2018-06-30$117.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-08
-$3.00K
10-Q · filed 2019-08-08
-$1.17M
derived: sum of 3 quarters · filed 2019-09-23
-$1.11M
derived: sum of 4 quarters · filed 2019-09-23
2018-03-31-$120.00K
10-Q · filed 2019-05-08
-$1.29M
derived: sum of 2 quarters · filed 2019-09-23
-$1.23M
derived: sum of 3 quarters · filed 2019-09-23
$17.00K
derived: sum of 4 quarters · filed 2019-09-23
2017-12-31-$1.17M
derived: 10-K/A 12 month − 10-Q 9 month · filed 2019-09-23
-$1.11M
derived: sum of 2 quarters · filed 2019-09-23
$137.00K
derived: sum of 3 quarters · filed 2019-09-23
$195.00K
10-K/A · filed 2019-09-23
2017-09-30$55.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-06
$1.30M
derived: sum of 2 quarters · filed 2018-11-06
$1.36M
10-Q · filed 2018-11-06
$1.59M
derived: sum of 4 quarters · filed 2018-11-06
2017-06-30$1.25M
derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-06
$1.31M
10-Q · filed 2018-08-06
$1.54M
derived: sum of 3 quarters · filed 2018-08-06
2017-03-31$58.00K
10-Q · filed 2018-05-15
$291.00K
derived: sum of 2 quarters · filed 2018-05-15
2016-12-31$233.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-09
-$126.00K
10-K · filed 2018-03-09
2016-09-30-$359.00K
10-Q · filed 2017-11-14

Similar stocks

Stock NameCountryMarket CapPE Ratio
SOLIGENIX, INC. (SNGX)United States$0.008B
Imunon, Inc. (IMNN)United States$0.008B-0.56
Ensysce Biosciences, Inc. (ENSC)United States$0.008B-0.37
InMed Pharmaceuticals Inc. (INM)$0.008B-0.65
Apimeds Pharmaceuticals US, Inc. (APUS)United States$0.008B
Traws Pharma, Inc. (TRAW)United States$0.009B-0.58
Alzamend Neuro, Inc. (ALZN)United States$0.009B
CNS Pharmaceuticals, Inc. (CNSP)United States$0.007B
Acurx Pharmaceuticals, Inc. (ACXP)United States$0.007B-0.97
FibroBiologics, Inc. (FBLG)United States$0.009B-0.27